×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

SeaSpine Holdings Corp. (SPNE) NASDAQ

$9.54 - (-)

Market Cap: -

As of 01/04/23 12:00 AM EST. Market closed.

(SPNE)

SeaSpine Holdings Corp. (SPNE)
NASDAQ

$9.54
- (-)

Market Cap: -

As of 01/04/23 12:00 AM EST. Market closed.

Add to Portfolio

SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to ... read more

SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Keith Valentine
Full Time Employees
421
CEO Compensation (Base)
$547,324
CEO Compensation (Total)
$1.99M
URL
Address
5770 Armada Dr, California, Carlsbad, 92008-4608.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Keith Valentine
Full Time Employees
421
CEO Compensation (Base)
$547,324
CEO Compensation (Total)
$1.99M
Address
5770 Armada Dr, California, Carlsbad, 92008-4608.
PRICE CHART FOR SEASPINE HOLDINGS CORP
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.77
Previous Close
$9.54
Days Range
$8.43 - $9.67
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
37,202,800
Open
$8.77
Previous Close
$9.54
Days Range
$8.43 - $9.67
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
37,202,800
FINANCIAL STATEMENTS FOR SEASPINE HOLDINGS CORP
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SEASPINE HOLDINGS CORP
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Winge John J.Vice President, SalesJan 01, 2023 Option Exercise$8.352,49020,79290,951Jan 03, 2023, 05:25 PM
Lipschultz TylerSVP, Orthobiologics and BDJan 01, 2023 Option Exercise$8.353,41128,482131,284Jan 03, 2023, 05:24 PM
Keran Patrick LSVP, General CounselJan 01, 2023 Option Exercise$8.353,10825,95269,628Jan 03, 2023, 05:24 PM
Cirino DennisSVP, Global Spinal SystemsJan 01, 2023 Option Exercise$8.353,15026,30348,556Jan 03, 2023, 05:23 PM
Benny Paul S.VP, TreasurerJan 01, 2023 Option Exercise$8.354253,54920,950Jan 03, 2023, 05:23 PM
Bostjancic John J.Chief Financial OfficerJan 01, 2023 Option Exercise$8.353,28127,396102,563Jan 03, 2023, 05:23 PM
Valentine KeithChief Executive OfficerJan 01, 2023 Option Exercise$8.357,17059,870333,797Jan 03, 2023, 05:22 PM
Maniar ShwetaDirectorDec 29, 2022 Sale$8.003,78630,28823,993Dec 30, 2022, 04:29 PM
Benny Paul S.VP, TreasurerDec 28, 2022 Option Exercise$4.921,3206,49420,334Dec 30, 2022, 04:28 PM
Lipschultz TylerSVP, Orthobiologics and BDDec 28, 2022 Option Exercise$4.922,50012,300126,333Dec 30, 2022, 04:28 PM
Standish BeauPresident, Enabling TechJul 14, 2022 Sale$5.7350,000286,5000Jul 15, 2022, 04:25 PM
Winge John J.Vice President, SalesJun 30, 2022 Option Exercise$4.801,7858,56888,573Jul 01, 2022, 05:08 PM
Cirino DennisSVP, Global Spinal SystemsJun 30, 2022 Option Exercise$4.802,38411,44346,354Jul 01, 2022, 05:07 PM
Benny Paul S.VP, TreasurerJun 30, 2022 Option Exercise$4.801,2616,05319,014Jul 01, 2022, 05:07 PM
Valentine KeithChief Executive OfficerJun 30, 2022 Option Exercise$4.802,38511,448328,784Jul 01, 2022, 05:07 PM
BRADLEY KEITHDirectorJun 02, 2022 Option Exercise$7.773192,47988,592Jun 03, 2022, 05:22 PM
Gaeta ReneeDirectorMar 14, 2022 Sale$12.032,00024,06020,113Mar 15, 2022, 04:06 PM
BRADLEY KEITHDirectorMar 02, 2022 Option Exercise$13.253749072,968Mar 04, 2022, 05:55 PM
Gaeta ReneeDirectorFeb 14, 2022 Sale$12.062,00024,12022,113Feb 16, 2022, 06:31 PM
Winge John J.Vice President, SalesJan 28, 2022 Option Exercise$11.392,23525,45786,788Feb 01, 2022, 07:18 PM
Lipschultz TylerSVP, Orthobiologics and BDJan 28, 2022 Option Exercise$11.392,24325,548123,833Feb 01, 2022, 07:17 PM
Keran Patrick LSVP, General CounselJan 28, 2022 Option Exercise$11.392,11324,06767,456Feb 01, 2022, 07:17 PM
Cirino DennisSVP, Global Spinal SystemsJan 28, 2022 Option Exercise$11.393,06734,93343,970Feb 01, 2022, 07:17 PM
Bostjancic John J.Chief Financial OfficerJan 28, 2022 Option Exercise$11.393,62841,323100,269Feb 01, 2022, 07:16 PM
Valentine KeithChief Executive OfficerJan 28, 2022 Option Exercise$11.3913,798157,159326,399Feb 01, 2022, 07:16 PM
Gaeta ReneeDirectorJan 10, 2022 Sale$12.352,00024,70024,113Jan 10, 2022, 05:23 PM
Lipschultz TylerSVP, Orthobiologics and BDJan 01, 2022 Option Exercise$13.624,80165,390119,592Jan 04, 2022, 09:22 PM
Keran Patrick LSVP, General CounselJan 01, 2022 Option Exercise$13.625,12169,74865,487Jan 04, 2022, 09:22 PM
Cirino DennisSVP, Global Spinal SystemsJan 01, 2022 Option Exercise$13.625,18370,59241,136Jan 04, 2022, 09:21 PM
Bostjancic John J.Chief Financial OfficerJan 01, 2022 Option Exercise$13.626,44087,71396,978Jan 04, 2022, 09:21 PM
Winge John J.Vice President, SalesJan 01, 2022 Option Exercise$13.624,08355,61081,807Jan 04, 2022, 09:20 PM
Winge John J.Vice President, SalesDec 31, 2021 Option Exercise$11.585216,03377,910Jan 04, 2022, 09:20 PM
Valentine KeithChief Executive OfficerJan 01, 2022 Option Exercise$13.6211,167152,095314,001Jan 04, 2022, 09:20 PM
Valentine KeithChief Executive OfficerDec 31, 2021 Option Exercise$8.921,0269,152305,196Jan 04, 2022, 09:20 PM
BRADLEY KEITHDirectorDec 02, 2021 Option Exercise$13.383749573,005Dec 03, 2021, 04:19 PM
BRADLEY KEITHDirectorSep 02, 2021 Option Exercise$16.953762773,042Sep 03, 2021, 05:04 PM
FEKETE MICHAELDirectorAug 20, 2021 Buy$14.8010,000148,00088,370Sep 02, 2021, 04:06 PM
Standish BeauPresident, Enabling TechJul 21, 2021 Sale$19.2410,100194,3390Jul 23, 2021, 04:33 PM
Standish BeauPresident, Enabling TechJul 16, 2021 Sale$19.248,054154,93210,100Jul 19, 2021, 08:15 PM
Standish BeauPresident, Enabling TechJul 15, 2021 Sale$18.8318,154341,86518,154Jul 19, 2021, 08:15 PM
Cirino DennisSVP, Global Spinal SystemsJul 02, 2021 Option Exercise$20.234,56792,39037,545Jul 02, 2021, 07:08 PM
Cirino DennisSVP, Global Spinal SystemsJun 30, 2021 Option Exercise$8.922,38321,25628,905Jul 02, 2021, 07:08 PM
Lipschultz TylerSVP, Orthobiologics and BDJun 30, 2021 Option Exercise$8.922,38321,256112,467Jul 02, 2021, 07:08 PM
Valentine KeithChief Executive OfficerJun 30, 2021 Option Exercise$8.921,35612,096304,170Jul 02, 2021, 07:07 PM
BRADLEY KEITHDirectorJun 30, 2021 Option Exercise$20.513673873,079Jul 02, 2021, 07:06 PM
BRADLEY KEITHDirectorJun 03, 2021 Option Exercise$20.283827,74772,323Jun 04, 2021, 04:14 PM
BRADLEY KEITHDirectorMar 31, 2021 Option Exercise$17.404273163,201Apr 01, 2021, 07:21 PM
Gaeta ReneeDirectorMar 08, 2021 Sale$18.282,92053,37818,533Mar 08, 2021, 04:05 PM
Gaeta ReneeDirectorFeb 22, 2021 Sale$17.763,00053,28021,453Feb 23, 2021, 04:16 PM
Cirino DennisSVP, Global Spinal SystemsJan 01, 2021 Option Exercise$17.455,13789,64126,522Jan 05, 2021, 04:14 PM
Keran Patrick LVP, General CounselJan 01, 2021 Option Exercise$17.4511,308197,32568,127Jan 05, 2021, 04:14 PM
Bostjancic John J.Chief Financial OfficerJan 01, 2021 Option Exercise$17.4512,851224,25092,497Jan 05, 2021, 04:14 PM
Valentine KeithChief Executive OfficerJan 01, 2021 Option Exercise$17.4525,450444,103302,814Jan 05, 2021, 04:13 PM
Valentine KeithChief Executive OfficerDec 31, 2020 Option Exercise$8.921,0589,437280,865Jan 05, 2021, 04:13 PM
Lipschultz TylerSVP, Orthobiologics and BDJan 01, 2021 Option Exercise$17.4511,349198,040110,084Jan 05, 2021, 12:00 AM
Winge John J.Vice President, SalesJan 01, 2021 Option Exercise$17.459,090158,62177,389Jan 05, 2021, 12:00 AM
Lipschultz TylerSVP, Orthobiologics and BDDec 31, 2020 Option Exercise$8.921,13410,11596,956Jan 05, 2021, 12:00 AM
BRADLEY KEITHDirectorDec 31, 2020 Option Exercise$17.454273362,310Jan 04, 2021, 04:07 PM
BRADLEY KEITHDirectorSep 30, 2020 Option Exercise$14.305274461,421Oct 02, 2020, 04:07 PM
HENNEMAN JOHN B IIIDirectorAug 05, 2020 Sale$15.0010,000150,00060,458Aug 05, 2020, 07:39 PM
Cirino DennisSVP, Global Spinal SystemsJul 02, 2020 Option Exercise$10.444,56747,67922,886Jul 06, 2020, 04:06 PM
Winge John J.Vice President, SalesJun 30, 2020 Option Exercise$8.901,26511,25867,540Jul 02, 2020, 04:12 PM
Lipschultz TylerSVP, Orthobiologics and BDJun 30, 2020 Option Exercise$8.901,13310,08495,822Jul 02, 2020, 04:11 PM
Cirino DennisSVP, Global Spinal SystemsJun 30, 2020 Option Exercise$8.902,16219,24214,247Jul 02, 2020, 04:10 PM
Valentine KeithChief Executive OfficerJun 30, 2020 Option Exercise$8.901,20210,698279,807Jul 02, 2020, 04:09 PM
BRADLEY KEITHDirectorMay 29, 2020 Option Exercise$10.653804,04751,849Jun 02, 2020, 04:40 PM
CARUSO RICHARD E10% OwnerApr 29, 2020 Sale$10.564,92151,95915,457May 01, 2020, 05:36 PM
CARUSO RICHARD E10% OwnerApr 29, 2020 Option Exercise$9.434,92146,40520,378May 01, 2020, 05:36 PM
BRADLEY KEITHDirectorFeb 29, 2020 Option Exercise$14.135476352,229Mar 02, 2020, 08:37 PM
Winge John J.Vice President, SalesJan 01, 2020 Option Exercise$12.0113,598163,31266,275Jan 02, 2020, 09:18 PM
Winge John J.Vice President, SalesDec 31, 2019 Option Exercise$10.215275,38151,443Jan 02, 2020, 09:18 PM
Lipschultz TylerSVP, Orthobiologics and BDJan 01, 2020 Option Exercise$12.0111,623139,59294,689Jan 02, 2020, 09:17 PM
Lipschultz TylerSVP, Orthobiologics and BDDec 31, 2019 Option Exercise$10.219589,78174,625Jan 02, 2020, 09:17 PM
Valentine KeithChief Executive OfficerJan 01, 2020 Option Exercise$12.0138,128457,917278,605Jan 02, 2020, 09:17 PM
Valentine KeithChief Executive OfficerDec 31, 2019 Option Exercise$10.215936,055245,578Jan 02, 2020, 09:17 PM
Keran Patrick LVP, General CounselJan 01, 2020 Option Exercise$12.0115,573187,03258,895Jan 02, 2020, 09:17 PM
Bostjancic John J.Chief Financial OfficerJan 01, 2020 Option Exercise$12.0118,286219,61581,877Jan 02, 2020, 09:16 PM
Cirino DennisSVP, Global Spinal SystemsJan 01, 2020 Option Exercise$12.011,39916,80212,085Jan 02, 2020, 09:16 PM
Valentine KeithChief Executive OfficerDec 13, 2019 Buy$11.1220,000222,400244,985Dec 13, 2019, 03:51 PM
BRADLEY KEITHDirectorNov 29, 2019 Option Exercise$13.235471452,283Dec 02, 2019, 07:50 PM
BRADLEY KEITHDirectorAug 29, 2019 Option Exercise$11.145460252,337Sep 03, 2019, 04:36 PM
Cirino DennisSVP, Global Spinal SystemsJul 02, 2019 Option Exercise$12.794,56758,41210,063Jul 03, 2019, 04:07 PM
Cirino DennisSVP, Global Spinal SystemsJun 28, 2019 Option Exercise$11.261,42416,0381,424Jul 03, 2019, 04:07 PM
Winge John J.Vice President, SalesJun 28, 2019 Option Exercise$11.261,04211,73650,916Jul 02, 2019, 04:34 PM
Valentine KeithChief Executive OfficerJun 28, 2019 Option Exercise$11.2699411,195224,985Jul 02, 2019, 04:34 PM
Lipschultz TylerSVP, Orthobiologics and BDJun 28, 2019 Option Exercise$11.267298,21073,667Jul 02, 2019, 12:00 AM
BRADLEY KEITHDirectorMay 30, 2019 Option Exercise$14.014496,29052,391May 31, 2019, 04:14 PM
CARUSO RICHARD E10% OwnerMay 06, 2019 Sale$15.175,02076,15315,457May 08, 2019, 04:22 PM
CARUSO RICHARD E10% OwnerMay 06, 2019 Option Exercise$14.155,02071,03320,477May 08, 2019, 04:22 PM
BRADLEY KEITHDirectorFeb 28, 2019 Option Exercise$15.345076740,858Mar 01, 2019, 04:54 PM
ESSIG STUARTDirectorFeb 15, 2019 Sale$16.087,976128,2540Feb 15, 2019, 05:51 PM
ESSIG STUARTDirectorFeb 15, 2019 Sale$16.087,976128,2540Feb 15, 2019, 05:51 PM
ESSIG STUARTDirectorFeb 14, 2019 Sale$16.099,000144,8107,976Feb 15, 2019, 05:51 PM
ESSIG STUARTDirectorFeb 14, 2019 Sale$16.099,000144,8107,976Feb 15, 2019, 05:51 PM
ESSIG STUARTDirectorFeb 12, 2019 Sale$16.1410,124163,40117,976Feb 13, 2019, 06:13 PM
ESSIG STUARTDirectorFeb 11, 2019 Sale$16.014,45071,24528,100Feb 13, 2019, 06:13 PM
ESSIG STUARTDirectorFeb 11, 2019 Sale$16.014,45071,24528,100Feb 13, 2019, 06:13 PM
ESSIG STUARTDirectorFeb 13, 2019 Sale$16.011,00016,01016,976Feb 13, 2019, 06:13 PM
ESSIG STUARTDirectorFeb 13, 2019 Sale$16.011,00016,01016,976Feb 13, 2019, 06:13 PM
ESSIG STUARTDirectorFeb 12, 2019 Sale$16.1410,124163,40117,976Feb 13, 2019, 06:13 PM
Valentine KeithChief Executive OfficerJan 01, 2019 Option Exercise$18.2423,611430,665224,031Jan 03, 2019, 12:00 AM
Keran Patrick LVP, General CounselJan 01, 2019 Option Exercise$18.249,914180,83143,671Jan 03, 2019, 12:00 AM
Winge John J.Vice President, SalesJan 01, 2019 Option Exercise$18.248,038146,61349,925Jan 03, 2019, 12:00 AM
Lipschultz TylerSVP, Orthobiologics and BDJan 01, 2019 Option Exercise$18.244,66185,01772,973Jan 03, 2019, 12:00 AM
Bostjancic John J.Chief Financial OfficerJan 01, 2019 Option Exercise$18.2410,144185,02766,694Jan 03, 2019, 12:00 AM
Valentine KeithChief Executive OfficerDec 31, 2018 Option Exercise$6.431,2067,750184,276Jan 03, 2019, 12:00 AM
Keran Patrick LVP, General CounselDec 31, 2018 Option Exercise$6.431,1227,21026,127Jan 03, 2019, 12:00 AM
Winge John J.Vice President, SalesDec 31, 2018 Option Exercise$6.431,5449,92232,646Jan 03, 2019, 12:00 AM
Lipschultz TylerSVP, Orthobiologics and BDDec 31, 2018 Option Exercise$6.431,0466,72249,511Jan 03, 2019, 12:00 AM
BRADLEY KEITHDirectorNov 30, 2018 Option Exercise$19.665098340,908Dec 03, 2018, 06:27 PM
BRADLEY KEITHDirectorAug 30, 2018 Option Exercise$14.875074340,958Aug 31, 2018, 05:46 PM
HENNEMAN JOHN B IIIDirectorAug 29, 2018 Sale$14.653,40749,91354,708Aug 29, 2018, 06:03 PM
HENNEMAN JOHN B IIIDirectorAug 28, 2018 Sale$14.652,02929,72558,115Aug 29, 2018, 06:03 PM
HENNEMAN JOHN B IIIDirectorAug 27, 2018 Sale$14.724,56467,18260,144Aug 29, 2018, 06:03 PM
ESSIG STUARTDirectorAug 02, 2018 Option Exercise$13.6043,496591,546458,425Aug 03, 2018, 04:29 PM
ESSIG STUARTDirectorAug 02, 2018 Sale$14.0043,496608,944414,929Aug 03, 2018, 04:29 PM
Keran Patrick LVP, General CounselJun 29, 2018 Option Exercise$6.432,18514,04125,005Jun 29, 2018, 06:17 PM
Valentine KeithChief Executive OfficerJun 29, 2018 Option Exercise$6.432,10113,501183,070Jun 29, 2018, 06:16 PM
Winge John J.Vice President, SalesJun 29, 2018 Option Exercise$6.431,76311,32931,102Jun 29, 2018, 06:16 PM
Lipschultz TylerSVP, Orthobiologics and BDJun 29, 2018 Option Exercise$6.432,26114,52948,465Jun 29, 2018, 06:15 PM
BRADLEY KEITHDirectorJun 14, 2018 Option Exercise$14.031712,39941,008Jun 14, 2018, 08:00 PM
HENNEMAN JOHN B IIIDirectorJun 13, 2018 Option Exercise$12.4417,398216,43164,708Jun 13, 2018, 07:50 PM
BRADLEY KEITHDirectorMay 18, 2018 Option Exercise$11.632,60930,34330,502May 21, 2018, 07:06 PM
BRADLEY KEITHDirectorMay 18, 2018 Sale$11.962,60931,20427,893May 21, 2018, 07:06 PM
Bostjancic John J.Chief Financial OfficerMar 23, 2018 Option Exercise$9.753663,56948,715Apr 02, 2018, 08:31 PM
Winge John J.Vice President, SalesMar 23, 2018 Option Exercise$9.751771,72629,339Apr 02, 2018, 08:30 PM
BRADLEY KEITHDirectorMar 14, 2018 Option Exercise$9.971711,70527,893Mar 15, 2018, 01:26 PM
Winge John J.Vice President, SalesJan 01, 2018 Option Exercise$10.125,51855,84229,516Jan 03, 2018, 08:10 PM
Winge John J.Vice President, SalesDec 31, 2017 Option Exercise$6.431,59410,24320,675Jan 03, 2018, 08:10 PM
Valentine KeithChief Executive OfficerDec 31, 2017 Option Exercise$6.431,2668,135145,031Jan 03, 2018, 08:10 PM
Keran Patrick LVP, General CounselJan 01, 2018 Option Exercise$10.126,61366,92422,820Jan 03, 2018, 08:10 PM
Keran Patrick LVP, General CounselDec 31, 2017 Option Exercise$6.431,1847,60813,860Jan 03, 2018, 08:10 PM
Baker Brian D.VP, Global OperationsJan 01, 2018 Option Exercise$10.125,59356,60122,044Jan 03, 2018, 08:09 PM
Baker Brian D.VP, Global OperationsDec 31, 2017 Option Exercise$6.431,56310,04414,844Jan 03, 2018, 08:09 PM
BRADLEY KEITHDirectorDec 14, 2017 Option Exercise$10.011711,71228,064Dec 14, 2017, 06:22 PM
FEKETE MICHAELDirectorNov 08, 2017 Buy$10.255605,74032,304Nov 13, 2017, 01:00 PM
FEKETE MICHAELDirectorNov 10, 2017 Buy$10.259309,53333,234Nov 13, 2017, 01:00 PM
BRADLEY KEITHDirectorSep 14, 2017 Option Exercise$10.391711,77728,235Sep 15, 2017, 10:31 AM
Keran Patrick LVP, General CounselJun 30, 2017 Option Exercise$6.432,12213,63612,676Jul 05, 2017, 03:37 PM
Valentine KeithChief Executive OfficerJun 30, 2017 Option Exercise$6.432,04013,109143,765Jul 05, 2017, 03:35 PM
Stephenson Kirtley C.DirectorJun 30, 2017 Option Exercise$11.521,62818,75544,188Jul 05, 2017, 01:37 PM
SULLIVAN JAMES MDirectorJun 30, 2017 Option Exercise$11.521,08612,51139,205Jul 05, 2017, 01:36 PM
Winge John J.Vice President, SalesJun 30, 2017 Option Exercise$6.431,71211,00119,081Jul 05, 2017, 12:00 AM
Baker Brian D.VP, Global OperationsJun 30, 2017 Option Exercise$6.431,74311,20113,281Jul 05, 2017, 12:00 AM
BRADLEY KEITHDirectorJun 07, 2017 Option Exercise$10.001131,13013,285Jun 08, 2017, 02:02 PM
SULLIVAN JAMES MDirectorApr 25, 2017 Option Exercise$6.922,60918,05422,998Apr 26, 2017, 11:11 AM
SULLIVAN JAMES MDirectorMar 31, 2017 Option Exercise$7.851,59312,50520,389Apr 03, 2017, 02:06 PM
Stephenson Kirtley C.DirectorMar 31, 2017 Option Exercise$7.852,38918,75419,878Apr 03, 2017, 02:04 PM
Bostjancic John J.Chief Financial OfficerMar 23, 2017 Option Exercise$7.343652,67941,556Mar 27, 2017, 03:18 PM
Bostjancic John J.Chief Financial OfficerMar 24, 2017 Option Exercise$7.321,43510,50440,121Mar 27, 2017, 03:18 PM
Winge John J.Vice President, SalesMar 24, 2017 Option Exercise$7.324293,14017,369Mar 27, 2017, 02:21 PM
Winge John J.Vice President, SalesMar 23, 2017 Option Exercise$7.341861,36517,798Mar 27, 2017, 02:21 PM
FEKETE MICHAELDirectorMar 15, 2017 Buy$6.655,10033,91515,110Mar 16, 2017, 11:41 AM
Baker Brian D.VP, Global OperationsMar 13, 2017 Sale$6.664,10027,30611,538Mar 14, 2017, 12:22 PM
Winge John J.Vice President, SalesMar 13, 2017 Sale$6.663,23021,51217,984Mar 14, 2017, 12:20 PM
Keran Patrick LVP, General CounselMar 13, 2017 Sale$6.666,31542,05810,554Mar 14, 2017, 12:13 PM
ESSIG STUARTDirectorMar 13, 2017 Buy$6.6750,000333,500378,946Mar 14, 2017, 12:11 PM
BRADLEY KEITHDirectorMar 07, 2017 Option Exercise$6.7811376613,398Mar 09, 2017, 12:12 PM
BRADLEY KEITHDirectorDec 07, 2016 Option Exercise$7.3111382613,511Mar 09, 2017, 12:10 PM
BRADLEY KEITHDirectorSep 07, 2016 Option Exercise$10.671131,20613,624Mar 09, 2017, 12:08 PM
Stephenson Kirtley C.DirectorDec 31, 2016 Option Exercise$7.902,37418,75517,489Jan 04, 2017, 11:25 AM
Winge John J.Vice President, SalesDec 31, 2016 Option Exercise$6.725903,96211,177Jan 04, 2017, 11:22 AM
SULLIVAN JAMES MDirectorDec 31, 2016 Option Exercise$7.901,58312,50618,813Jan 04, 2017, 11:21 AM
Valentine KeithChief Executive OfficerDec 31, 2016 Option Exercise$6.722701,813101,687Jan 04, 2017, 11:16 AM
BRADLEY KEITHDirectorDec 07, 2016 Option Exercise$7.313762,74912,985Dec 08, 2016, 03:07 PM
BRADLEY KEITHDirectorSep 07, 2016 Option Exercise$10.673764,01213,361Nov 22, 2016, 02:14 PM
Winge John J.Vice President, SalesMar 23, 2016 Option Exercise$14.231892,68910,173Nov 22, 2016, 02:13 PM
Winge John J.Vice President, SalesMar 25, 2016 Option Exercise$14.082643,7179,482Nov 22, 2016, 02:13 PM
Winge John J.Vice President, SalesMar 24, 2016 Option Exercise$14.084276,0129,746Nov 22, 2016, 02:13 PM
Bostjancic John J.Chief Financial OfficerJul 01, 2016 Option Exercise$11.062,15923,87922,429Nov 22, 2016, 12:54 PM
Bostjancic John J.Chief Financial OfficerMar 25, 2016 Option Exercise$14.081,03014,50219,588Nov 22, 2016, 12:54 PM
Bostjancic John J.Chief Financial OfficerMar 24, 2016 Option Exercise$14.081,40719,81120,618Nov 22, 2016, 12:54 PM
Bostjancic John J.Chief Financial OfficerMar 23, 2016 Option Exercise$14.233735,30822,025Nov 22, 2016, 12:54 PM
Bostjancic John J.Chief Financial OfficerNov 18, 2016 Buy$7.023,90027,37826,329Nov 22, 2016, 12:54 PM
Valentine KeithChief Executive OfficerNov 18, 2016 Buy$7.0025,000175,000101,417Nov 21, 2016, 06:26 PM
Winge John J.Vice President, SalesJun 30, 2016 Option Exercise$8.911,1059,84611,467Jul 01, 2016, 01:37 PM
Valentine KeithChief Executive OfficerJun 30, 2016 Option Exercise$8.911,31711,73476,417Jul 01, 2016, 01:36 PM
Baker Brian D.VP, Global OperationsJun 30, 2016 Option Exercise$8.911,0529,3735,652Jul 01, 2016, 01:34 PM
Keran Patrick LGeneral CounselJun 30, 2016 Option Exercise$8.911,37012,2071,370Jul 01, 2016, 01:32 PM
Valentine KeithChief Executive OfficerMay 23, 2016 Buy$10.065,00050,30075,100May 24, 2016, 12:51 PM
Valentine KeithChief Executive OfficerMay 20, 2016 Buy$10.255,00051,25070,100May 24, 2016, 12:51 PM
Bostjancic John J.Chief Financial OfficerMay 20, 2016 Buy$10.344,32644,73127,398May 23, 2016, 04:53 PM
Bostjancic John J.Chief Financial OfficerMay 19, 2016 Buy$10.166746,84823,072May 23, 2016, 04:53 PM
Winge John J.VP, SalesAug 18, 2015 Buy$15.215,31580,84110,362Sep 09, 2015, 06:31 PM
Bostjancic John J.Chief Financial OfficerSep 02, 2015 Buy$14.052,50035,12522,398Sep 04, 2015, 05:03 PM
Baker Brian D.VP, Global OperationsAug 27, 2015 Buy$14.964,60068,8164,600Aug 31, 2015, 03:45 PM
Stephenson Kirtley C.DirectorAug 19, 2015 Buy$15.399,700149,2839,700Aug 21, 2015, 08:48 PM
ESSIG STUARTDirectorAug 20, 2015 Buy$15.3812,225188,02165,100Aug 20, 2015, 08:34 PM
ESSIG STUARTDirectorAug 19, 2015 Buy$15.3117,661270,39052,875Aug 20, 2015, 08:34 PM
ESSIG STUARTDirectorAug 18, 2015 Buy$15.3235,214539,47835,214Aug 20, 2015, 08:34 PM
Valentine KeithChief Executive OfficerAug 20, 2015 Buy$15.3812,225188,02165,100Aug 20, 2015, 08:33 PM
Valentine KeithChief Executive OfficerAug 19, 2015 Buy$15.3117,661270,39052,875Aug 20, 2015, 08:33 PM
Valentine KeithChief Executive OfficerAug 18, 2015 Buy$15.3235,214539,47835,214Aug 20, 2015, 08:33 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Winge John J.Vice President, Sales01/01/202320,792
Lipschultz TylerSVP, Orthobiologics and BD01/01/202328,482
Keran Patrick LSVP, General Counsel01/01/202325,952
Cirino DennisSVP, Global Spinal Systems01/01/202326,303
Benny Paul S.VP, Treasurer01/01/20233,549
Bostjancic John J.Chief Financial Officer01/01/202327,396
Valentine KeithChief Executive Officer01/01/202359,870
Maniar ShwetaDirector12/29/202230,288
Benny Paul S.VP, Treasurer12/28/20226,494
Lipschultz TylerSVP, Orthobiologics and BD12/28/202212,300
Standish BeauPresident, Enabling Tech07/14/2022286,500
Winge John J.Vice President, Sales06/30/20228,568
Cirino DennisSVP, Global Spinal Systems06/30/202211,443
Benny Paul S.VP, Treasurer06/30/20226,053
Valentine KeithChief Executive Officer06/30/202211,448
BRADLEY KEITHDirector06/02/20222,479
Gaeta ReneeDirector03/14/202224,060
BRADLEY KEITHDirector03/02/2022490
Gaeta ReneeDirector02/14/202224,120
Winge John J.Vice President, Sales01/28/202225,457
Lipschultz TylerSVP, Orthobiologics and BD01/28/202225,548
Keran Patrick LSVP, General Counsel01/28/202224,067
Cirino DennisSVP, Global Spinal Systems01/28/202234,933
Bostjancic John J.Chief Financial Officer01/28/202241,323
Valentine KeithChief Executive Officer01/28/2022157,159
Gaeta ReneeDirector01/10/202224,700
Lipschultz TylerSVP, Orthobiologics and BD01/01/202265,390
Keran Patrick LSVP, General Counsel01/01/202269,748
Cirino DennisSVP, Global Spinal Systems01/01/202270,592
Bostjancic John J.Chief Financial Officer01/01/202287,713
Winge John J.Vice President, Sales01/01/202255,610
Winge John J.Vice President, Sales12/31/20216,033
Valentine KeithChief Executive Officer01/01/2022152,095
Valentine KeithChief Executive Officer12/31/20219,152
BRADLEY KEITHDirector12/02/2021495
BRADLEY KEITHDirector09/02/2021627
FEKETE MICHAELDirector08/20/2021148,000
Standish BeauPresident, Enabling Tech07/21/2021194,339
Standish BeauPresident, Enabling Tech07/16/2021154,932
Standish BeauPresident, Enabling Tech07/15/2021341,865
Cirino DennisSVP, Global Spinal Systems07/02/202192,390
Cirino DennisSVP, Global Spinal Systems06/30/202121,256
Lipschultz TylerSVP, Orthobiologics and BD06/30/202121,256
Valentine KeithChief Executive Officer06/30/202112,096
BRADLEY KEITHDirector06/30/2021738
BRADLEY KEITHDirector06/03/20217,747
BRADLEY KEITHDirector03/31/2021731
Gaeta ReneeDirector03/08/202153,378
Gaeta ReneeDirector02/22/202153,280
Cirino DennisSVP, Global Spinal Systems01/01/202189,641
Keran Patrick LVP, General Counsel01/01/2021197,325
Bostjancic John J.Chief Financial Officer01/01/2021224,250
Valentine KeithChief Executive Officer01/01/2021444,103
Valentine KeithChief Executive Officer12/31/20209,437
Lipschultz TylerSVP, Orthobiologics and BD01/01/2021198,040
Winge John J.Vice President, Sales01/01/2021158,621
Lipschultz TylerSVP, Orthobiologics and BD12/31/202010,115
BRADLEY KEITHDirector12/31/2020733
BRADLEY KEITHDirector09/30/2020744
HENNEMAN JOHN B IIIDirector08/05/2020150,000
Cirino DennisSVP, Global Spinal Systems07/02/202047,679
Winge John J.Vice President, Sales06/30/202011,258
Lipschultz TylerSVP, Orthobiologics and BD06/30/202010,084
Cirino DennisSVP, Global Spinal Systems06/30/202019,242
Valentine KeithChief Executive Officer06/30/202010,698
BRADLEY KEITHDirector05/29/20204,047
CARUSO RICHARD E10% Owner04/29/202051,959
CARUSO RICHARD E10% Owner04/29/202046,405
BRADLEY KEITHDirector02/29/2020763
Winge John J.Vice President, Sales01/01/2020163,312
Winge John J.Vice President, Sales12/31/20195,381
Lipschultz TylerSVP, Orthobiologics and BD01/01/2020139,592
Lipschultz TylerSVP, Orthobiologics and BD12/31/20199,781
Valentine KeithChief Executive Officer01/01/2020457,917
Valentine KeithChief Executive Officer12/31/20196,055
Keran Patrick LVP, General Counsel01/01/2020187,032
Bostjancic John J.Chief Financial Officer01/01/2020219,615
Cirino DennisSVP, Global Spinal Systems01/01/202016,802
Valentine KeithChief Executive Officer12/13/2019222,400
BRADLEY KEITHDirector11/29/2019714
BRADLEY KEITHDirector08/29/2019602
Cirino DennisSVP, Global Spinal Systems07/02/201958,412
Cirino DennisSVP, Global Spinal Systems06/28/201916,038
Winge John J.Vice President, Sales06/28/201911,736
Valentine KeithChief Executive Officer06/28/201911,195
Lipschultz TylerSVP, Orthobiologics and BD06/28/20198,210
BRADLEY KEITHDirector05/30/20196,290
CARUSO RICHARD E10% Owner05/06/201976,153
CARUSO RICHARD E10% Owner05/06/201971,033
BRADLEY KEITHDirector02/28/2019767
ESSIG STUARTDirector02/15/2019128,254
ESSIG STUARTDirector02/15/2019128,254
ESSIG STUARTDirector02/14/2019144,810
ESSIG STUARTDirector02/14/2019144,810
ESSIG STUARTDirector02/12/2019163,401
ESSIG STUARTDirector02/11/201971,245
ESSIG STUARTDirector02/11/201971,245
ESSIG STUARTDirector02/13/201916,010
ESSIG STUARTDirector02/13/201916,010
ESSIG STUARTDirector02/12/2019163,401
Valentine KeithChief Executive Officer01/01/2019430,665
Keran Patrick LVP, General Counsel01/01/2019180,831
Winge John J.Vice President, Sales01/01/2019146,613
Lipschultz TylerSVP, Orthobiologics and BD01/01/201985,017
Bostjancic John J.Chief Financial Officer01/01/2019185,027
Valentine KeithChief Executive Officer12/31/20187,750
Keran Patrick LVP, General Counsel12/31/20187,210
Winge John J.Vice President, Sales12/31/20189,922
Lipschultz TylerSVP, Orthobiologics and BD12/31/20186,722
BRADLEY KEITHDirector11/30/2018983
BRADLEY KEITHDirector08/30/2018743
HENNEMAN JOHN B IIIDirector08/29/201849,913
HENNEMAN JOHN B IIIDirector08/28/201829,725
HENNEMAN JOHN B IIIDirector08/27/201867,182
ESSIG STUARTDirector08/02/2018591,546
ESSIG STUARTDirector08/02/2018608,944
Keran Patrick LVP, General Counsel06/29/201814,041
Valentine KeithChief Executive Officer06/29/201813,501
Winge John J.Vice President, Sales06/29/201811,329
Lipschultz TylerSVP, Orthobiologics and BD06/29/201814,529
BRADLEY KEITHDirector06/14/20182,399
HENNEMAN JOHN B IIIDirector06/13/2018216,431
BRADLEY KEITHDirector05/18/201830,343
BRADLEY KEITHDirector05/18/201831,204
Bostjancic John J.Chief Financial Officer03/23/20183,569
Winge John J.Vice President, Sales03/23/20181,726
BRADLEY KEITHDirector03/14/20181,705
Winge John J.Vice President, Sales01/01/201855,842
Winge John J.Vice President, Sales12/31/201710,243
Valentine KeithChief Executive Officer12/31/20178,135
Keran Patrick LVP, General Counsel01/01/201866,924
Keran Patrick LVP, General Counsel12/31/20177,608
Baker Brian D.VP, Global Operations01/01/201856,601
Baker Brian D.VP, Global Operations12/31/201710,044
BRADLEY KEITHDirector12/14/20171,712
FEKETE MICHAELDirector11/08/20175,740
FEKETE MICHAELDirector11/10/20179,533
BRADLEY KEITHDirector09/14/20171,777
Keran Patrick LVP, General Counsel06/30/201713,636
Valentine KeithChief Executive Officer06/30/201713,109
Stephenson Kirtley C.Director06/30/201718,755
SULLIVAN JAMES MDirector06/30/201712,511
Winge John J.Vice President, Sales06/30/201711,001
Baker Brian D.VP, Global Operations06/30/201711,201
BRADLEY KEITHDirector06/07/20171,130
SULLIVAN JAMES MDirector04/25/201718,054
SULLIVAN JAMES MDirector03/31/201712,505
Stephenson Kirtley C.Director03/31/201718,754
Bostjancic John J.Chief Financial Officer03/23/20172,679
Bostjancic John J.Chief Financial Officer03/24/201710,504
Winge John J.Vice President, Sales03/24/20173,140
Winge John J.Vice President, Sales03/23/20171,365
FEKETE MICHAELDirector03/15/201733,915
Baker Brian D.VP, Global Operations03/13/201727,306
Winge John J.Vice President, Sales03/13/201721,512
Keran Patrick LVP, General Counsel03/13/201742,058
ESSIG STUARTDirector03/13/2017333,500
BRADLEY KEITHDirector03/07/2017766
BRADLEY KEITHDirector12/07/2016826
BRADLEY KEITHDirector09/07/20161,206
Stephenson Kirtley C.Director12/31/201618,755
Winge John J.Vice President, Sales12/31/20163,962
SULLIVAN JAMES MDirector12/31/201612,506
Valentine KeithChief Executive Officer12/31/20161,813
BRADLEY KEITHDirector12/07/20162,749
BRADLEY KEITHDirector09/07/20164,012
Winge John J.Vice President, Sales03/23/20162,689
Winge John J.Vice President, Sales03/25/20163,717
Winge John J.Vice President, Sales03/24/20166,012
Bostjancic John J.Chief Financial Officer07/01/201623,879
Bostjancic John J.Chief Financial Officer03/25/201614,502
Bostjancic John J.Chief Financial Officer03/24/201619,811
Bostjancic John J.Chief Financial Officer03/23/20165,308
Bostjancic John J.Chief Financial Officer11/18/201627,378
Valentine KeithChief Executive Officer11/18/2016175,000
Winge John J.Vice President, Sales06/30/20169,846
Valentine KeithChief Executive Officer06/30/201611,734
Baker Brian D.VP, Global Operations06/30/20169,373
Keran Patrick LGeneral Counsel06/30/201612,207
Valentine KeithChief Executive Officer05/23/201650,300
Valentine KeithChief Executive Officer05/20/201651,250
Bostjancic John J.Chief Financial Officer05/20/201644,731
Bostjancic John J.Chief Financial Officer05/19/20166,848
Winge John J.VP, Sales08/18/201580,841
Bostjancic John J.Chief Financial Officer09/02/201535,125
Baker Brian D.VP, Global Operations08/27/201568,816
Stephenson Kirtley C.Director08/19/2015149,283
ESSIG STUARTDirector08/20/2015188,021
ESSIG STUARTDirector08/19/2015270,390
ESSIG STUARTDirector08/18/2015539,478
Valentine KeithChief Executive Officer08/20/2015188,021
Valentine KeithChief Executive Officer08/19/2015270,390
Valentine KeithChief Executive Officer08/18/2015539,478
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR SEASPINE HOLDINGS CORP
LOADING...